FDA Adverse Event Malfunction Summary report: N

UNICEL DXI 600 ACCESS® IMMUNOASSAY SYSTEM

MDR report key: 2190017 · Received August 4, 2011

Report

Report Number
2122870-2011-02668
Event Type
Malfunction
Date Received
August 4, 2011
Date of Event
June 24, 2011
Report Date
July 4, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
JJE
PMA / PMN Number
K023764
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PATIENT SAMPLE WAS LITHIUM HEPARIN PLASMA IN 13X100 GREINER VACUETTE PRIMARY TUBE. THE SAMPLE WAS CENTRIFUGED AT 3000 G FOR 15 MINUTES AT 19 DEGREES C. PER THE CUSTOMER, THE CUSTOMER NOTED THAT IT WAS A FULL SAMPLE AND THE APPEARANCE WAS CLEAR. PER THE CUSTOMER, THE INSTRUMENT PASSED A HIGH SENSITIVITY SYSTEM CHECK. A CARRYOVER TEST PERFORMED ON (B)(4) 2011 ALSO PASSED. THE CUSTOMER DID NOT PROVIDE SPECIFIC QC NOR SYSTEM CHECK DATA. ON (B)(4) 2011, A BEC FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED FOR THE EVENT. THE FSE CLEANED BOTH PRECISION PUMPS, REPLACED BOTH O-RINGS TO IMPROVE SEAL, AND VERIFIED ULTRASONICS AND ALIGNMENTS FOR BOTH PIPETTORS. A CLEAR ROOT CAUSE COULD NOT BE DETERMINED FOR THIS EVENT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER, INC (BEC) TO REPORT OBTAINING A FALSE POSITIVE TOTAL BETA HUMAN CHORIONIC GONADOTROPIN (THCG) FOR ONE (1) PATIENT, GENERATED BY A UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM, USED IN CONJUNCTION WITH ACCESS THCG REAGENT (LOT 018462) AND ACCESS THCG CALIBRATORS (LOT 014414). REPEAT TESTING OF THE SAMPLE ON THE SAME INSTRUMENT GENERATED A NEGATIVE RESULT, WHICH WAS REPORTED OUT OF THE LAB. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXI 600 ACCESS® IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER FOR CLINICAL USE JJE BECKMAN COULTER, INC. DXI 600 NA

Patients

Seq Age Sex Outcome Treatment
1